KV Pharmaceutical's Launch of Gestiva Delayed

January 26, 2009 -- KV Pharmaceutical has been notified that the pending New Drug Application for Gestiva (alpha hydroxyprogesterone caproate) will not be approved by the U.S. FDA until further conditions are met.

The details can be read here.